Cargando…
A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection?
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198145/ https://www.ncbi.nlm.nih.gov/pubmed/32389426 http://dx.doi.org/10.1016/j.lungcan.2020.04.029 |
| _version_ | 1783528940493602816 |
|---|---|
| author | Sereno, María Gutiérrez-Gutiérrez, Gerardo Sandoval, Carmen Falagan, Sandra Jimenez-Gordo, Ana María Merino, María López-Menchaca, Ramiro Martínez-Martin, Patricia Roa, Silvia Casado, Enrique |
| author_facet | Sereno, María Gutiérrez-Gutiérrez, Gerardo Sandoval, Carmen Falagan, Sandra Jimenez-Gordo, Ana María Merino, María López-Menchaca, Ramiro Martínez-Martin, Patricia Roa, Silvia Casado, Enrique |
| author_sort | Sereno, María |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7198145 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71981452020-05-05 A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? Sereno, María Gutiérrez-Gutiérrez, Gerardo Sandoval, Carmen Falagan, Sandra Jimenez-Gordo, Ana María Merino, María López-Menchaca, Ramiro Martínez-Martin, Patricia Roa, Silvia Casado, Enrique Lung Cancer Correspondence Published by Elsevier B.V. 2020-07 2020-05-04 /pmc/articles/PMC7198145/ /pubmed/32389426 http://dx.doi.org/10.1016/j.lungcan.2020.04.029 Text en © 2020 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Sereno, María Gutiérrez-Gutiérrez, Gerardo Sandoval, Carmen Falagan, Sandra Jimenez-Gordo, Ana María Merino, María López-Menchaca, Ramiro Martínez-Martin, Patricia Roa, Silvia Casado, Enrique A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? |
| title | A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? |
| title_full | A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? |
| title_fullStr | A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? |
| title_full_unstemmed | A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? |
| title_short | A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? |
| title_sort | favorable outcome of pneumonia covid 19 in an advanced lung cancer patient with severe neutropenia: is immunosuppression a risk factor for sars-cov2 infection? |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198145/ https://www.ncbi.nlm.nih.gov/pubmed/32389426 http://dx.doi.org/10.1016/j.lungcan.2020.04.029 |
| work_keys_str_mv | AT serenomaria afavorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT gutierrezgutierrezgerardo afavorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT sandovalcarmen afavorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT falagansandra afavorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT jimenezgordoanamaria afavorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT merinomaria afavorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT lopezmenchacaramiro afavorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT martinezmartinpatricia afavorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT roasilvia afavorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT casadoenrique afavorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT serenomaria favorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT gutierrezgutierrezgerardo favorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT sandovalcarmen favorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT falagansandra favorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT jimenezgordoanamaria favorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT merinomaria favorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT lopezmenchacaramiro favorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT martinezmartinpatricia favorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT roasilvia favorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection AT casadoenrique favorableoutcomeofpneumoniacovid19inanadvancedlungcancerpatientwithsevereneutropeniaisimmunosuppressionariskfactorforsarscov2infection |